Specific disturbances of proximal tubular transport are caused by a deficiency of a specific tubular transporter. The range of symptoms include mere abnormalities in blood or urine up to severe organ damage. The management usually consists in sufficient supplementation.
1. |
de Ligt J et al. (2012) Diagnostic exome sequencing in persons with severe intellectual disability. |
2. |
Raychowdhury R et al. (1989) Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. |
3. |
Chatelet F et al. (1986) Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. II. Extrarenal distribution. |
4. |
Kerjaschki D et al. (1983) Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. |
5. |
Moestrup SK et al. (1995) Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. |
6. |
Farquhar MG et al. (1995) The Heymann nephritis antigenic complex: megalin (gp330) and RAP. |
7. |
Chowdhary BP et al. (1995) In situ hybridization mapping of a 500-kDa calcium-sensing protein gene (LRP2) to human chromosome region 2q31>q32.1 and porcine chromosome region 15q22>q24. |
8. |
None (1995) The unfolding story of megalin (gp330): now recognized as a drug receptor. |
9. |
Kounnas MZ et al. (1995) Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. |
10. |
Saito A et al. (1994) Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. |
11. |
Korenberg JR et al. (1994) Chromosomal localization of human genes for the LDL receptor family member glycoprotein 330 (LRP2) and its associated protein RAP (LRPAP1). |
12. |
Donnai D et al. (1993) Diaphragmatic hernia, exomphalos, absent corpus callosum, hypertelorism, myopia, and sensorineural deafness: a newly recognized autosomal recessive disorder? |
13. |
Hjälm G et al. (1996) Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with potential intracellular signaling properties. |
14. |
Willnow TE et al. (1996) Defective forebrain development in mice lacking gp330/megalin. |
16. |
Nykjaer A et al. (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. |
17. |
Marinò M et al. (1999) Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis. |
18. |
Leheste JR et al. (1999) Megalin knockout mice as an animal model of low molecular weight proteinuria. |
19. |
Schmitz C et al. (2002) Megalin deficiency offers protection from renal aminoglycoside accumulation. |
20. |
Nykjaer A et al. (2001) Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). |
21. |
Chassaing N et al. (2003) Donnai-Barrow syndrome: four additional patients. |
22. |
Nagai M et al. (2003) The adaptor protein ARH escorts megalin to and through endosomes. |
23. |
Tramontano A et al. (2004) Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in Heymann nephritis. |
24. |
Hammes A et al. (2005) Role of endocytosis in cellular uptake of sex steroids. |
25. |
Naccache SN et al. (2006) Binding of internalized receptors to the PDZ domain of GIPC/synectin recruits myosin VI to endocytic vesicles. |
26. |
Caruso-Neves C et al. (2006) PKB and megalin determine the survival or death of renal proximal tubule cells. |
27. |
Kantarci S et al. (2007) Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes. |
28. |
Fyfe JC et al. (1991) Inherited selective intestinal cobalamin malabsorption and cobalamin deficiency in dogs. |
29. |
Aminoff M et al. (1995) Selective intestinal malabsorption of vitamin B12 displays recessive mendelian inheritance: assignment of a locus to chromosome 10 by linkage. |
30. |
Bork P et al. (1993) The CUB domain. A widespread module in developmentally regulated proteins. |
31. |
Seetharam B et al. (1997) Identification of rat yolk sac target protein of teratogenic antibodies, gp280, as intrinsic factor-cobalamin receptor. |
32. |
Birn H et al. (1997) Characterization of an epithelial approximately 460-kDa protein that facilitates endocytosis of intrinsic factor-vitamin B12 and binds receptor-associated protein. |
33. |
Moestrup SK et al. (1998) The intrinsic factor-vitamin B12 receptor and target of teratogenic antibodies is a megalin-binding peripheral membrane protein with homology to developmental proteins. |
35. |
Aminoff M et al. (1999) Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. |
36. |
Kozyraki R et al. (1999) The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. |
37. |
Xu D et al. (1999) Genetic evidence of an accessory activity required specifically for cubilin brush-border expression and intrinsic factor-cobalamin absorption. |
38. |
Kristiansen M et al. (2000) Cubilin P1297L mutation associated with hereditary megaloblastic anemia 1 causes impaired recognition of intrinsic factor-vitamin B(12) by cubilin. |
39. |
Fyfe JC et al. (2004) The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless. |
40. |
Andersen CB et al. (2010) Structural basis for receptor recognition of vitamin-B(12)-intrinsic factor complexes. |
41. |
Storm T et al. (2011) A patient with cubilin deficiency. |
42. |
None (1979) Abstracts of meeting presentations. |
43. |
Tedesco TA et al. (1975) The genetic defect in galactosemia. |
44. |
Kaufman F et al. (1979) Ovarian failure in galactosaemia. |
45. |
Litchfield WJ et al. (1978) Effect of galactose on free radical reactions of polymorphonuclear leukocytes. |
46. |
Levy HL et al. (1977) Sepsis due to Escherichia coli in neonates with galactosemia. |
47. |
Ibarra B et al. (1979) Los Angeles variant of galactose-1-phosphate uridyltransferase (EC 2.7.7.12) in a Mexican family. |
48. |
Tedesco TA et al. (1979) Galactosemia: alterations in sulfate metabolism secondary to galactose-1-phosphate uridyltransferase deficiency. |
49. |
Benson PF et al. (1979) Prenatal diagnosis of galactosaemia in six pregnancies -- possible complications with rare alleles of the galactose 1-phosphate uridyl transferase locus. |
50. |
Wharton CH et al. (1978) Galactose-1-phosphate accumulation by a Duarte-transferase deficiency double heterozygote. |
51. |
Bruns GA et al. (1978) Expression of ACONS and GALT in man-rodent somatic cell hybrids. |
52. |
Hammersen G et al. (1975) Rennes-like variant of galactosemia: clinical and biochemical studies. |
53. |
Gitzelmann R et al. (1992) Hypergalactosaemia and portosystemic encephalopathy due to persistence of ductus venosus Arantii. |
54. |
Waggoner DD et al. (1990) Long-term prognosis in galactosaemia: results of a survey of 350 cases. |
55. |
Brivet M et al. (1989) Lens hexitols and cataract formation during lactation in a woman heterozygote for galactosaemia. |
56. |
Brivet M et al. (1989) Effect of lactation in a mother with galactosemia. |
57. |
Harley JD et al. (1974) Maternal enzymes of galactose metabolism and the "inexplicable" infantile cataract. |
58. |
Sun NC et al. (1974) Chromosome assignment of the human gene for galactose-1-phosphate uridyltransferase. |
59. |
Hill HZ et al. (1973) Detection of inborn errors of metabolism: galactosemia. |
60. |
Bergren WG et al. (1973) A new variant of galactose-1-phosphate uridyltransferase in man: the Los Angeles variant. |
61. |
Shih VE et al. (1971) Galactosemia screening of newborns in Massachusetts. |
62. |
Tedesco TA et al. (1971) Galactosemia: evidence for a structural gene mutation. |
63. |
Kelly S et al. (1972) A Duarte variant with clinical signs. |
64. |
Haschemian G et al. (1972) [A family with galactosemia and "Duarte variant"]. |
65. |
Nadler HL et al. (1970) Interallelic complementation in hybrid cells derived from human diploid strains deficient in galactose-1-phosphate uridyl transferase activity. |
66. |
None (1967) Clinical variants of galactosemia. |
67. |
Gitzelmann R et al. (1967) Partial galactose-1-phosphate uridyltransferase deficiency due to a variant enzyme. |
68. |
Sparkes RS et al. (1968) Galactosemia in a 24-year-old man; detection by enzyme studies. |
69. |
Cuatrecasas P et al. (1966) Galactose conversion to D-xylulose: an alternate route of galactose metabolism. |
70. |
Vaccaro AM et al. (1984) Polymorphism of erythrocyte galactose-1-phosphate uridyl-transferase in Italy: segregation analysis in 693 families. |
71. |
Shih LY et al. (1984) Gene dosage studies supporting localization of the structural gene for galactose-1-phosphate uridyl transferase (GALT) to band p13 of chromosome 9. |
72. |
Eriksen B et al. (1980) Human red cell galactose-1-phosphate uridylyltransferase (EC 2.7.7.12). Electrophoretically determined polymorphism in Denmark and its use in paternity cases. |
73. |
Lang A et al. (1980) A new variant of galactosemia: galactose-1-phosphate uridylytransferase sensitive to product inhibition by glucose 1-phosphate. |
74. |
Sparkes RS et al. (1980) Probable linkage between the human galactose-1-P uridyl transferase locus and 9qh. |
75. |
Mulcahy MT et al. (1980) Where is the gene for GALT? |
76. |
Eydoux P et al. (1981) Gene dosage effect for GALT in 9p trisomy and in 9p tetrasomy with an improved technique for GALT determination. |
77. |
Dagna Bricarelli F et al. (1981) Expression of GALT in two unrelated 9p- patients. Evidence for assignment of the GALT locus to the 9p21 band. |
78. |
Xu YK et al. (1983) Polymorphism of erythrocyte galactose-1-phosphate uridyltransferase among Chinese. |
79. |
Andersen MW et al. (1984) Transferase-deficiency galactosemia: immunochemical studies of the Duarte and Los Angeles variants. |
80. |
Andersen MW et al. (1983) Transferase-deficiency galactosemia: evidence for the lack of a transferase protein in galactosemic red cells. |
81. |
Robinson AC et al. (1984) Hypergonadotrophic hypogonadism in classical galactosaemia: evidence for defective oogenesis. Case report. |
82. |
Garcia-Cruz D et al. (1982) Tetrasomy 9p: clinical aspects and enzymatic gene dosage expression. |
83. |
Urbanowski JC et al. (1982) Nonenzymatically galactosylated serum albumin in a galactosemic infant. |
84. |
Ashino J et al. (1995) Molecular characterization of galactosemia (type 1) mutations in Japanese. |
85. |
Lin HC et al. (1995) Linkage disequilibrium between a SacI restriction fragment length polymorphism and two galactosemia mutations. |
86. |
Elsas LJ et al. (1995) Galactosemia: a strategy to identify new biochemical phenotypes and molecular genotypes. |
87. |
Elsas LJ et al. (1994) A common mutation associated with the Duarte galactosemia allele. |
88. |
Schweitzer S et al. (1993) Long-term outcome in 134 patients with galactosaemia. |
89. |
Elsevier JP et al. (1996) Heterodimer formation and activity in the human enzyme galactose-1-phosphate uridylyltransferase. |
90. |
Elsevier JP et al. (1996) The Q188R mutation in human galactose-1-phosphate uridylyltransferase acts as a partial dominant negative. |
91. |
Levy HL et al. (1996) Vitreous hemorrhage as an ophthalmic complication of galactosemia. |
92. |
Langley SD et al. (1997) Molecular basis for Duarte and Los Angeles variant galactosemia. |
93. |
Tyfield L et al. (1999) Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. |
94. |
Kozák L et al. (1999) Presence of a deletion in the 5' upstream region of the GALT gene in Duarte (D2) alleles. |
95. |
Murphy M et al. (1999) Genetic basis of transferase-deficient galactosaemia in Ireland and the population history of the Irish Travellers. |
96. |
de Jongh S et al. (1999) Spontaneous pregnancy in a patient with classical galactosaemia. |
97. |
Ruiz M et al. (1999) Galactosaemia presenting as congenital pseudoafibrinogenaemia. |
98. |
Elsas LJ et al. () The molecular biology of galactosemia. |
99. |
Suzuki M et al. (2001) Large-scale molecular screening for galactosemia alleles in a pan-ethnic population. |
100. |
Webb AL et al. (2003) Verbal dyspraxia and galactosemia. |
101. |
DAWSON SP et al. (1960) Galactosemia. A genetic study of four generations by enzyme assay. |
102. |
WALKER FA et al. (1962) Galactosemia: a study of twenty-seven kindreds in North America. |
103. |
BEUTLER E et al. (1965) A NEW GENETIC ABNORMALITY RESULTING IN GALACTOSE-1-PHOSPHATE URIDYLTRANSFERASE DEFICIENCY. |
104. |
Segal S et al. (2006) Pathways of galactose metabolism by galactosemics: evidence for galactose conversion to hepatic UDPglucose. |
105. |
None (2006) Classical galactosaemia revisited. |
106. |
Feillet F et al. (2008) Evidence of cataplerosis in a patient with neonatal classical galactosemia presenting as citrin deficiency. |
107. |
Carney AE et al. (2009) Origins, distribution and expression of the Duarte-2 (D2) allele of galactose-1-phosphate uridylyltransferase. |
108. |
OMIM.ORG article Omim 230400 |